down arrow

Norris Medicines

33
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE744C01029
  • NSEID:
  • BSEID: 524414
INR
16.30
0.3 (1.88%)
BSENSE

Apr 11, 12:34 PM

BSE+NSE Vol: 858

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -32.57% vs -11.44% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -120.05% vs 1,383.29% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -75.35% vs 1.26% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 32.17% vs 46.39% in Mar 2023

Compare Profit and Loss Results of Norris Medicines
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5.00
9,264.00
-9,259.00
-99.95%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5.00
9,264.00
-9,259.00
-99.95%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-25.00
25.00
100.00%
Raw Materials Consumed
3.00
2,933.00
-2,930.00
-99.90%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
1.00
1,982.00
-1,981.00
-99.95%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5.00
6,939.00
-6,934.00
-99.93%
Operating Profit (PBDIT) excl Other Income
0.00
2,325.00
-2,325.00
-100.00%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
0.00
2,592.00
-2,592.00
-100.00%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
0.00
2,577.00
-2,577.00
-100.00%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
-1.00
2,259.00
-2,260.00
-100.04%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-1.00
2,259.00
-2,260.00
-100.04%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
-1.00
1,823.00
-1,824.00
-100.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-24.00
7,868.00
-7,892.00
-100.31%
Profit Available for appropriations
-25.00
9,691.00
-9,716.00
-100.26%
Appropriations
-25.00
9,691.00
-9,716.00
-100.26%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.19
45.52
-46.71
-102.61%
Profit And Loss - Net Sales
Net Sales 5.64 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -32.57% vs -11.44% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.18 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -120.05% vs 1,383.29% in Mar 2023

Profit And Loss - Interest
Interest 0.37 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -75.35% vs 1.26% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -1.19 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 32.17% vs 46.39% in Mar 2023